Zhejiang Orient Gene Biotech Co Ltd (688298) — Cash Flow Reinvestment Rate
Zhejiang Orient Gene Biotech Co Ltd (688298) has a Cash Flow Reinvestment Rate of 0.50x as of September 2022, reinvesting CN¥155.73 Million (capex CN¥119.58 Million plus investments CN¥36.14 Million) from operating cash flow of CN¥309.89 Million. Explore Zhejiang Orient Gene Biotech Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Orient Gene Biotech Co Ltd Cash Flow Reinvestment Rate (2016–2022)
Historical reinvestment intensity for Zhejiang Orient Gene Biotech Co Ltd across 7 annual periods. Also explore balance sheet size of Zhejiang Orient Gene Biotech Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Zhejiang Orient Gene Biotech Co Ltd (2016–2022)
Year-by-year capital reinvestment analysis for Zhejiang Orient Gene Biotech Co Ltd. For live market cap and broader valuation context, see Zhejiang Orient Gene Biotech Co Ltd market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.71x | CN¥2.13 Billion | CN¥3.00 Billion | CN¥1.05 Billion | ▲ +402.2% |
| 2021 | 0.14x | CN¥736.03 Million | CN¥5.20 Billion | CN¥507.87 Million | ▼ -55.1% |
| 2020 | 0.31x | CN¥563.93 Million | CN¥1.79 Billion | CN¥126.93 Million | ▼ -96.2% |
| 2019 | 8.28x | CN¥448.90 Million | CN¥54.21 Million | CN¥11.90 Million | ▼ -19.5% |
| 2018 | 10.28x | CN¥455.88 Million | CN¥44.33 Million | CN¥18.88 Million | ▼ -23.4% |
| 2017 | 13.43x | CN¥450.38 Million | CN¥33.54 Million | CN¥13.38 Million | ▲ +76.0% |
| 2016 | 7.63x | CN¥90.11 Million | CN¥11.81 Million | CN¥4.65 Million | — |